Panbela Therapeutics, Inc. Proceeds from Convertible Debt
Panbela Therapeutics, Inc. reported Proceeds from Convertible Debt of $810.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2021-03-25
- Panbela Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-12-31 was $0.00.
- Panbela Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-09-30 was $0.00.
- Panbela Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-06-30 was $0.00.
- Panbela Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-03-31 was $810.00K.
- Panbela Therapeutics, Inc. proceeds from convertible debt for fiscal 2019 was $810.00K, a 39.05% decline from fiscal 2018.
- Panbela Therapeutics, Inc. proceeds from convertible debt for fiscal 2018 was $1.33M, a 56.55% decline from fiscal 2017.
- Panbela Therapeutics, Inc. proceeds from convertible debt for fiscal 2017 was $3.06M.
| Period end | Proceeds from Convertible Debt 1 month | Proceeds from Convertible Debt 1 month as first filed | Proceeds from Convertible Debt 2 month | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $810.00K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $810.00K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $810.00K 10-Q · filed 2020-08-11 | |||||
| 2019-03-31 | $810.00K 10-Q · filed 2020-05-12 | ||||||
| 2019-01-31 | $817.00K 10-Q · filed 2019-05-14 | ||||||
| 2018-12-31 | $1.33M 10-K · filed 2020-03-24 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $0.00 derived: sum of 2 quarters · filed 2019-03-22 | $0.00 derived: sum of 3 quarters · filed 2019-03-22 | $3.06M 10-K · filed 2019-03-22 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $3.06M 10-Q · filed 2018-11-05 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $3.06M 10-Q · filed 2018-08-13 | |||||
| 2017-03-31 | $3.10M 10-Q · filed 2017-11-14 | $3.06M 10-Q · filed 2018-05-14 | |||||
| 2014-01-31 | $2.40M 10-K · filed 2016-03-08 | $100.00K 10-Q · filed 2015-11-16 | $3.10M 10-K · filed 2016-03-08 | ||||
| 2013-12-31 | $700.00K 10-K · filed 2016-03-08 | $3.10M 10-K · filed 2017-03-30 |